Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,633 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The family history of rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-positive patient is not a predictor of poor clinical presentation and treatment response with modern classification criteria and treatment strategy: the ANSWER cohort study.
Murata K, Hashimoto M, Yamamoto W, Son Y, Amuro H, Nagai K, Takeuchi T, Katayama M, Maeda Y, Ebina K, Hara R, Jinno S, Onishi A, Murakami K, Tanaka M, Ito H, Mimori T, Matsuda S. Murata K, et al. Among authors: maeda y. Rheumatol Int. 2020 Feb;40(2):217-225. doi: 10.1007/s00296-019-04464-9. Epub 2019 Oct 16. Rheumatol Int. 2020. PMID: 31620864
Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population.
Kishikawa T, Maeda Y, Nii T, Motooka D, Matsumoto Y, Matsushita M, Matsuoka H, Yoshimura M, Kawada S, Teshigawara S, Oguro E, Okita Y, Kawamoto K, Higa S, Hirano T, Narazaki M, Ogata A, Saeki Y, Nakamura S, Inohara H, Kumanogoh A, Takeda K, Okada Y. Kishikawa T, et al. Among authors: maeda y. Ann Rheum Dis. 2020 Jan;79(1):103-111. doi: 10.1136/annrheumdis-2019-215743. Epub 2019 Nov 7. Ann Rheum Dis. 2020. PMID: 31699813 Free PMC article.
Increased levels of plasma nucleotides in patients with rheumatoid arthritis.
Kishikawa T, Maeda Y, Nii T, Arase N, Hirata J, Suzuki K, Yamamoto K, Masuda T, Ogawa K, Tsuji S, Matsushita M, Matsuoka H, Yoshimura M, Tsunoda S, Ohshima S, Narazaki M, Ogata A, Saeki Y, Inohara H, Kumanogoh A, Takeda K, Okada Y. Kishikawa T, et al. Among authors: maeda y. Int Immunol. 2021 Jan 28;33(2):119-124. doi: 10.1093/intimm/dxaa059. Int Immunol. 2021. PMID: 32866240 Free PMC article.
Recovery from prolonged thrombocytopenia in patients with TAFRO syndrome: case series and literature review.
Yamaguchi Y, Maeda Y, Shibahara T, Nameki S, Nakabayashi A, Komuta K, Mizuno Y, Yagita M, Manabe Y, Morita T, Nishide M, Watanabe A, Takamatsu H, Nishida S, Hirano T, Shima Y, Narazaki M, Kumanogoh A. Yamaguchi Y, et al. Among authors: maeda y. Mod Rheumatol Case Rep. 2020 Jul;4(2):302-309. doi: 10.1080/24725625.2020.1717747. Epub 2020 Feb 3. Mod Rheumatol Case Rep. 2020. PMID: 33087016 Review.
The proliferative activity levels of each immune cell population evaluated by mass cytometry are linked to the clinical phenotypes of systemic lupus erythematosus.
Kajihara A, Morita T, Kato Y, Konaka H, Murakami T, Yamaguchi Y, Koyama S, Takamatsu H, Nishide M, Maeda Y, Watanabe A, Nishida S, Hirano T, Shima Y, Narazaki M, Kumanogoh A. Kajihara A, et al. Among authors: maeda y. Int Immunol. 2023 Jan 21;35(1):27-41. doi: 10.1093/intimm/dxac042. Int Immunol. 2023. PMID: 35997780 Free PMC article.
Persistence of SARS-CoV-2 neutralizing antibodies and anti-Omicron IgG induced by BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic disease: an explanatory study in Japan.
Yamaguchi Y, Nameki S, Kato Y, Saita R, Sato T, Nagao S, Murakami T, Yoshimine Y, Amiya S, Morita T, Okita Y, Kawasaki T, Fujimoto J, Ueda Y, Maeda Y, Watanabe A, Takamatsu H, Nishida S, Shima Y, Narazaki M, Kumanogoh A. Yamaguchi Y, et al. Among authors: maeda y. Lancet Reg Health West Pac. 2023 Mar;32:100661. doi: 10.1016/j.lanwpc.2022.100661. Epub 2022 Dec 20. Lancet Reg Health West Pac. 2023. PMID: 36569794 Free PMC article.
Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study.
Ebina K, Hirano T, Maeda Y, Yamamoto W, Hashimoto M, Murata K, Takeuchi T, Nagai K, Son Y, Amuro H, Onishi A, Jinno S, Hara R, Katayama M, Yamamoto K, Kumanogoh A, Hirao M. Ebina K, et al. Among authors: maeda y. Clin Rheumatol. 2020 Sep;39(9):2563-2572. doi: 10.1007/s10067-020-05015-5. Epub 2020 Mar 11. Clin Rheumatol. 2020. PMID: 32162152
Comparison of efficacy between anti-IL-6 receptor antibody and other biological disease-modifying antirheumatic drugs in the patients with rheumatoid arthritis who have knee joint involvement: the ANSWER cohort, retrospective study.
Maeda Y, Hirano T, Ebina K, Hara R, Hashimoto M, Yamamoto W, Murakami K, Kotani T, Hata K, Son Y, Amuro H, Onishi A, Jinno S, Katayama M, Kumanogoh A. Maeda Y, et al. Rheumatol Int. 2021 Jul;41(7):1233-1241. doi: 10.1007/s00296-021-04862-y. Epub 2021 Apr 26. Rheumatol Int. 2021. PMID: 33903963
4,633 results